entertainment -WSS

entertainment

author：comprehensive 2025-10-01 22:49:56 - browse：34521

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Food makers tried to stack nutrition panel with preferred experts

knowledge

WSS

Diverse clinical trials: Why aren’t we there yet?

Texas Medical Board asked to define abortion emergency exception

Why Novartis is going to walk from its acquisition of MorphoSys

IRA could hurt research into orphan drugs for rare diseases

Pig kidney works a record two months in donated body

FDA approves updated Covid vaccines

leisure time

entertainment

hotspot

Cancer drug shortages should be causing more outrage

Bernie brings in new pharma CEOs to talk drug prices

Affirmative action in medical school literally saved lives

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Supreme Court strikes down use of affirmative action

How housing is health care on Long Island

ChatGPT in medicine: STAT answers readers' burning questions

Telehealth for opioid use disorder is lifesaving

Medical leaders decry Supreme Court decision on affirmative action

Food makers to regulators: Ultra

entertainment

Popular nasal decongestant doesn't actually relieve congestion

Texas Medical Board asked to define abortion emergency exception

Why Novartis is going to walk from its acquisition of MorphoSys

New Covid vaccine is recommended for everyone 6 months or older

Will the IRA bring competition to the biologics market?

A single Democrat is willing to weaken Medicare negotiation power

knowledge

knowledge

explore

leisure time